Article

Managing Lung Cancer Patients Through the COVID-19 Pandemic: What to Know

Author(s):

Join top leaders in the lung cancer field as they share their insights on COVID-19 and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system on Thursday, May 14, 2020 at 8 PM EST.

Date/Time: Thursday, May 14, 2020 at 8 PM EST

Join oncologists nationwide who have learned from the top leaders in the lung cancer field as they share their insights on COVID-19 and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system.

Led by Nathan A. Pennell, MD, PhD; Stephen Liu, MD; H. Jack West, MD; Charu Aggarwal, MD, MPH, this webinar will cover all of the key information on treating your patients with lung cancer, who could be at risk for developing COVID-19.

Click here to register today!

Speakers:
Nathan A. Pennell, MD, PhD, Associate Professor; Director, Lung Cancer Medical Oncology Program,Cleveland Clinic, Cleveland, OH

Stephen Liu, MD, Associate Professor of Medicine; Director, Thoracic Oncology, Georgetown University, Washington, DC

Charu Aggarwal, MD, MPH, Leslye M. Heisler Assistant Professor of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

H. Jack West, MD, Associate Clinical Professor in Medical Oncology; Executive Director, Employer Services, City of Hope Comprehensive
Cancer Center, Irwindale, CA

Anna F. Farago, MD, PhD, Guest Speaker; Medical Oncologist, The Center for Thoracic Cancers at Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School Boston, Massachusetts

Related Videos
Steven H. Lin, MD, PhD
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the next steps for biomarker testing in NSCLC.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on tissue and liquid biopsies for biomarker testing in NSCLC.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the benefits of in-house biomarker testing in NSCLC.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on treatment planning after biomarker testing in NSCLC.